Exacerbation of sarcoidosis following interferon-alpha therapy for chronic active hepatitis C

Hye Jung Chang; Eun Hwa Choi; In Je Kim; Yun Su Sim; Jin Hwa Lee; Tae Hun Kim; Jin Wook Moon; Eun Mi Chun; Yoo Kyung Kim; Sun Hee Sung; Jung Hyun Chang

doi:10.4046/trd.2006.61.3.285

Exacerbation of sarcoidosis following interferon-alpha therapy for chronic active hepatitis C

Hye Jung Chang, Eun Hwa Choi, In Je Kim, Yun Su Sim, Jin Hwa Lee, Tae Hun Kim, Jin Wook Moon, Eun Mi Chun, Yoo Kyung Kim, Sun Hee Sung, Jung Hyun Chang

Research output: Contribution to journal › Article › peer-review

Abstract

Interferon alpha is an immunomodulator that is used as an antiviral agent to treat chronic active viral hepatitis C. However, interferon can induce or exacerbate sarcoidosis. We report a case of 42-year-old man with an exacerbation of pulmonary sarcoidosis after the cessation of interferon and ribavirin therapy for chronic hepatitis C. The patient's sarcoidosis improved spontaneously and he continues to be monitored regularly without steroid therapy.

Original language	English
Pages (from-to)	285-288
Number of pages	4
Journal	Tuberculosis and Respiratory Diseases
Volume	61
Issue number	3
DOIs	https://doi.org/10.4046/trd.2006.61.3.285
State	Published - Sep 2006

Keywords

Hepatitis C
Interferon
Sarcoidosis

Access to Document

10.4046/trd.2006.61.3.285

Cite this

@article{6d40c874a66c459e91fd4977f0a7eb4c,

title = "Exacerbation of sarcoidosis following interferon-alpha therapy for chronic active hepatitis C",

abstract = "Interferon alpha is an immunomodulator that is used as an antiviral agent to treat chronic active viral hepatitis C. However, interferon can induce or exacerbate sarcoidosis. We report a case of 42-year-old man with an exacerbation of pulmonary sarcoidosis after the cessation of interferon and ribavirin therapy for chronic hepatitis C. The patient's sarcoidosis improved spontaneously and he continues to be monitored regularly without steroid therapy.",

keywords = "Hepatitis C, Interferon, Sarcoidosis",

author = "Chang, {Hye Jung} and Choi, {Eun Hwa} and Kim, {In Je} and Sim, {Yun Su} and Lee, {Jin Hwa} and Kim, {Tae Hun} and Moon, {Jin Wook} and Chun, {Eun Mi} and Kim, {Yoo Kyung} and Sung, {Sun Hee} and Chang, {Jung Hyun}",

year = "2006",

month = sep,

doi = "10.4046/trd.2006.61.3.285",

language = "English",

volume = "61",

pages = "285--288",

journal = "Tuberculosis and Respiratory Diseases",

issn = "1738-3536",

publisher = "The Korean Academy of Tuberculosis and Respiratory Diseases",

number = "3",

}

TY - JOUR

T1 - Exacerbation of sarcoidosis following interferon-alpha therapy for chronic active hepatitis C

AU - Chang, Hye Jung

AU - Choi, Eun Hwa

AU - Kim, In Je

AU - Sim, Yun Su

AU - Lee, Jin Hwa

AU - Kim, Tae Hun

AU - Moon, Jin Wook

AU - Chun, Eun Mi

AU - Kim, Yoo Kyung

AU - Sung, Sun Hee

AU - Chang, Jung Hyun

PY - 2006/9

Y1 - 2006/9

N2 - Interferon alpha is an immunomodulator that is used as an antiviral agent to treat chronic active viral hepatitis C. However, interferon can induce or exacerbate sarcoidosis. We report a case of 42-year-old man with an exacerbation of pulmonary sarcoidosis after the cessation of interferon and ribavirin therapy for chronic hepatitis C. The patient's sarcoidosis improved spontaneously and he continues to be monitored regularly without steroid therapy.

AB - Interferon alpha is an immunomodulator that is used as an antiviral agent to treat chronic active viral hepatitis C. However, interferon can induce or exacerbate sarcoidosis. We report a case of 42-year-old man with an exacerbation of pulmonary sarcoidosis after the cessation of interferon and ribavirin therapy for chronic hepatitis C. The patient's sarcoidosis improved spontaneously and he continues to be monitored regularly without steroid therapy.

KW - Hepatitis C

KW - Interferon

KW - Sarcoidosis

UR - http://www.scopus.com/inward/record.url?scp=33845313943&partnerID=8YFLogxK

U2 - 10.4046/trd.2006.61.3.285

DO - 10.4046/trd.2006.61.3.285

M3 - Article

AN - SCOPUS:33845313943

SN - 1738-3536

VL - 61

SP - 285

EP - 288

JO - Tuberculosis and Respiratory Diseases

JF - Tuberculosis and Respiratory Diseases

IS - 3

ER -

Exacerbation of sarcoidosis following interferon-alpha therapy for chronic active hepatitis C

Abstract

Keywords

Access to Document

Fingerprint

Cite this